XML 30 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information
 9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Segment Information
SEGMENT INFORMATION
 
Three Months
 
Nine Months
 
2017
2016
 
2017
2016
Orthopaedics
$
1,132

$
1,077

 
$
3,408

$
3,216

MedSurg
1,336

1,253

 
3,977

3,469

Neurotechnology and Spine
538

503

 
1,588

1,483

Net sales
$
3,006

$
2,833

 
$
8,973

$
8,168

Orthopaedics
$
389

$
383

 
$
1,175

$
1,152

MedSurg
271

269

 
840

714

Neurotechnology and Spine
157

142

 
445

406

Segment operating income
$
817

$
794

 
$
2,460

$
2,272

Items not allocated to segments:
 
 
 
 
 
Corporate and other
(89
)
(88
)
 
(265
)
(258
)
Acquisition and integration-related charges
(11
)
(49
)
 
(29
)
(120
)
Amortization of intangible assets
(92
)
(89
)
 
(275
)
(230
)
Restructuring-related charges
(36
)
(25
)
 
(119
)
(67
)
Rejuvenate and ABG II and other recalls
(66
)
(57
)
 
(164
)
(104
)
Legal matters
—

—

 
(30
)
12

Consolidated operating income
$
523

$
486

 
$
1,578

$
1,505


There were no significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for 2016.